About this trial
The supply of oxygen is essential for energy production, recovery from efforts, and human life. Intermittent Hypoxia-Hyperoxia Exposure (IHHE) is a novel technique in which the subject is exposed to a respiratory environment with reduced oxygen fraction, controlled through a specific software, using a facial mask and a hypoxic generation device. The objective of this study is to determine if there is a relationship between intermittent hypoxia-hyperoxia exposure and cardiorespiratory condition, blood pressure, and arterial oxygen saturation.
According to our hypothesis, acute IHHE in elderly adults may influence cardiorespiratory condition, blood pressure, and arterial oxygen saturation.
The study will be conducted as a randomized clinical trial. The subjects will be divided into two groups: the experimental group will undergo an IHHE session, breathing air with an oxygen concentration (FiO2) ranging from 10-14% for 1-5 minutes, with 1-3 minutes of rest in hyperoxia (FiO2 30-40%) for a total of 4-8 cycles, based on their acute response to hypoxia. The placebo group will undergo a 5-cycle protocol with an FiO2 of 21%.
Eligibility criteria
Qualifiers
Being over 60 years old.
Having no previous experience in hypoxic training.
Engaging in less than 150 minutes of physical activity per week.
Disqualifiers
Having any pathology that prevents the subject from being independent in terms of walking and functionality.
Subjects with impaired cognitive abilities.
Subjects with pulmonary hypertension, decompensated heart or respiratory disease.
To have or have had cancer
Trial design
Treatments tested in this trial
- MITOVIT® Hypoxic Training System
- Sham MITOVIT® Hypoxic Training System
Treatment groups
Sponsors and collaborators
Sierra Varona SL
Lead sponsor
Universidad Europea de Madrid
Collaborator